Senaldi et al. demonstrated that complement activation occurs in SSc patients, with the highest level of activation being characteristic of dcSSc: serum levels of C3d, C3d:C3, Ba, and Ba:factor B were higher in dcSSc patients compared to lcSSc patients [27]. The gene discussed is CFB; the disease is systemic sclerosis.